Kimia Farma Persero Tbk (JK:KAEF) — Stock Price

Rp458.00 IDR
▼ -0.43% today

Kimia Farma Persero Tbk (JK:KAEF) is currently trading at Rp458.00 IDR, down 0.43% today. Over the past 52 weeks, shares have ranged between Rp390.00 and Rp715.00. This page tracks Kimia Farma Persero Tbk's live share price on the JK exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Kimia Farma Persero Tbk.

Kimia Farma Persero Tbk (KAEF) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Kimia Farma Persero Tbk's daily closing share price and trading volume on the JK exchange over the past year, giving a clear view of recent price momentum and liquidity.

Kimia Farma Persero Tbk Income Statement — Revenue, Profit & Earnings by Year

Kimia Farma Persero Tbk's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rp9.22 Trillion Rp9.94 Trillion Rp9.97 Trillion Rp9.23 Trillion Rp12.86 Trillion
Cost of Revenue Rp6.54 Trillion Rp6.99 Trillion Rp7.18 Trillion Rp6.01 Trillion Rp8.46 Trillion
Gross Profit Rp2.68 Trillion Rp2.95 Trillion Rp2.78 Trillion Rp3.52 Trillion Rp4.40 Trillion
Research & Development Rp41.13 Billion Rp31.62 Billion Rp108.10 Billion Rp46.37 Billion Rp41.35 Billion
SG&A Rp2.82 Trillion Rp237.85 Billion Rp440.64 Billion Rp321.91 Billion Rp378.34 Billion
Total Operating Expenses Rp2.93 Trillion Rp3.76 Trillion Rp4.35 Trillion Rp3.02 Trillion Rp3.06 Trillion
Operating Income Rp-248.17 Billion Rp-810.72 Billion Rp-1.57 Trillion Rp497.05 Billion Rp985.64 Billion
EBITDA Rp239.93 Billion Rp-265.60 Billion Rp-1.22 Trillion Rp1.02 Trillion Rp1.39 Trillion
EBIT Rp-248.17 Billion Rp-588.87 Billion Rp-1.54 Trillion Rp509.21 Billion Rp999.70 Billion
Interest Expense Rp586.32 Billion Rp425.68 Billion Rp622.82 Billion Rp525.61 Billion Rp606.81 Billion
Income Before Tax Rp-438.09 Billion Rp-1.23 Trillion Rp-2.17 Trillion Rp-16.39 Billion Rp392.88 Billion
Income Tax Expense Rp5.27 Billion Rp-21.53 Billion Rp-365.57 Billion Rp94.17 Billion Rp102.99 Billion
Net Income Rp-334.96 Billion Rp-842.27 Billion Rp-1.49 Trillion Rp-190.47 Billion Rp302.27 Billion

Kimia Farma Persero Tbk Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Kimia Farma Persero Tbk's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rp14.18 Trillion Rp14.97 Trillion Rp17.59 Trillion Rp20.35 Trillion Rp17.76 Trillion
Total Current Assets Rp3.98 Trillion Rp3.93 Trillion Rp5.89 Trillion Rp8.18 Trillion Rp6.30 Trillion
Cash & Equivalents Rp70.37 Billion Rp40.37 Billion Rp3.37 Billion Rp-4.86 Million Rp-1.54 Billion
Short-term Investments — Rp38.50 Billion Rp23.79 Billion Rp-1.08 Trillion Rp-1.09 Trillion
Net Receivables Rp1.21 Trillion Rp1.35 Trillion Rp2.10 Trillion Rp2.35 Trillion Rp2.19 Trillion
Inventory Rp1.38 Trillion Rp1.50 Trillion Rp2.48 Trillion Rp3.18 Trillion Rp2.76 Trillion
Property, Plant & Equipment Rp8.65 Trillion Rp9.56 Trillion Rp9.86 Trillion Rp10.28 Trillion Rp9.87 Trillion
Goodwill Rp53.68 Billion Rp53.68 Billion Rp107.56 Billion Rp134.44 Billion Rp134.44 Billion
Total Liabilities Rp11.67 Trillion Rp11.54 Trillion Rp11.19 Trillion Rp11.01 Trillion Rp10.53 Trillion
Total Current Liabilities Rp7.06 Trillion Rp7.95 Trillion Rp9.41 Trillion Rp8.69 Trillion Rp5.98 Trillion
Long-term Debt Rp3.38 Trillion Rp2.65 Trillion Rp730.40 Billion Rp1.67 Trillion Rp3.21 Trillion
Net Debt Rp6.55 Trillion Rp6.81 Trillion Rp6.87 Trillion Rp5.96 Trillion Rp7.28 Trillion
Total Stockholder Equity Rp2.66 Trillion Rp2.29 Trillion Rp5.89 Trillion Rp7.14 Trillion Rp7.14 Trillion
Retained Earnings Rp-5.47 Trillion Rp-5.14 Trillion Rp-2.51 Trillion Rp-170.05 Billion Rp302.27 Billion

Kimia Farma Persero Tbk Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Kimia Farma Persero Tbk generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rp236.75 Billion Rp153.62 Billion Rp-364.58 Billion Rp403.34 Billion Rp-223.92 Billion
Capital Expenditures Rp132.29 Billion Rp175.83 Billion Rp867.78 Billion Rp596.61 Billion Rp659.25 Billion
Free Cash Flow Rp104.46 Billion Rp-22.22 Billion Rp-1.10 Trillion Rp-465.33 Billion Rp-883.18 Billion
Investing Cash Flow Rp-138.41 Billion Rp34.40 Billion Rp-722.50 Billion Rp-429.39 Billion Rp-648.45 Billion
Financing Cash Flow Rp-159.55 Billion Rp-534.72 Billion Rp-272.03 Billion Rp1.46 Trillion Rp364.35 Billion
Dividends Paid — Rp78.62 Million Rp0.00 Rp9.02 Billion Rp702.22 Million
Stock-Based Compensation — — — — —
Depreciation Rp488.10 Billion — — Rp510.53 Billion Rp391.77 Billion
Change in Cash Rp-15.96 Billion Rp-345.94 Billion Rp-1.36 Trillion Rp1.44 Trillion Rp-501.51 Billion

Kimia Farma Persero Tbk Earnings History — EPS Actual vs. Analyst Estimates

Track Kimia Farma Persero Tbk's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 24, 2025 — — —
Oct 31, 2024 — — —
Jul 28, 2023 -3.98 — —
Apr 18, 2023 0.07 — —
Mar 29, 2023 1.96 — —
Oct 31, 2022 -37.97 — —
Sep 30, 2022 -37.97 — —
May 31, 2022 1.04 — —